Innovative BioSpine program attracts $2m grant from Insurance Commission
Griffith has secured a $2m grant from the Motor Accident Insurance Commission for the BioSpine program.
Griffith has secured a $2m grant from the Motor Accident Insurance Commission for the BioSpine program.
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
Leading Griffith University disability researcher and advocate, Professor Elizabeth Kendall, has been honoured with a Member of the Order of...
Griffith University’s BioSpine team, led by Dr Claudio Pizzolato, has won a coveted place in a health tech accelerator program...
A $3.8m funding boost for a crucial Griffith University research program focusing on digitally-enabled rehabilitation technology for spinal cord injury.
Griffith University’s world-first study into cell transplantation to repair injuries to the nervous system has received a major boost thanks to a $5.4 million funding extension from the MAIC.
Griffith promotes workforce diversity and inclusion during Disability Action Week and asks employers to ‘open-up to opportunity’.
A new partnership between Griffith and MAIC will examine the experiences of injured Aboriginal and Torres Strait Islanders and the Compulsory Third Party scheme.
Griffith medicine graduate and Biospine Project co-lead Dr Dinesh Palipana OAM has added Senior Lecturer in the School of Medicine to his growing list of Griffith affiliations.
How technologies can help the integration of rehabilitation services with remote and home healthcare is the focus of Dr Camila Shirota’s Advance Queensland Fellowship.